Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nexgel (NXGL) Other Accumulated Expenses (2018 - 2025)

Historic Other Accumulated Expenses for Nexgel (NXGL) over the last 8 years, with Q3 2025 value amounting to $255000.0.

  • Nexgel's Other Accumulated Expenses rose 9029.85% to $255000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $255000.0, marking a year-over-year increase of 9029.85%. This contributed to the annual value of $68000.0 for FY2024, which is 2608.7% down from last year.
  • Per Nexgel's latest filing, its Other Accumulated Expenses stood at $255000.0 for Q3 2025, which was up 9029.85% from $194000.0 recorded in Q2 2025.
  • Nexgel's Other Accumulated Expenses' 5-year high stood at $255000.0 during Q3 2025, with a 5-year trough of $7000.0 in Q2 2022.
  • Over the past 5 years, Nexgel's median Other Accumulated Expenses value was $68000.0 (recorded in 2024), while the average stood at $92933.3.
  • The largest annual percentage gain for Nexgel's Other Accumulated Expenses in the last 5 years was 84285.71% (2023), contrasted with its biggest fall of 7570.09% (2023).
  • Nexgel's Other Accumulated Expenses (Quarter) stood at $8000.0 in 2021, then surged by 550.0% to $52000.0 in 2022, then surged by 76.92% to $92000.0 in 2023, then dropped by 26.09% to $68000.0 in 2024, then surged by 275.0% to $255000.0 in 2025.
  • Its last three reported values are $255000.0 in Q3 2025, $194000.0 for Q2 2025, and $85000.0 during Q1 2025.